Rotherham Opts for Multilex DDF in MEDITECH

First DataBankThe Rotherham NHS Foundation Trust is adopting First DataBank's Multilex Drug Data File (Multilex DDF), the UK's leading drug knowledge base, as a key component of the Trust's MEDITECH Electronic Patient Record system.

The purchase of the latest MEDITECH v6.0 Electronic Patient Record solution from FileTek UK Ltd is part of a new strategic informatics direction for the Trust planned over the next ten years.

Brian James, CEO Rotherham Rotherham chief executive Brian James stated "This fully integrated electronic patient record will cover the entire patient journey within and beyond the hospital. Including First DataBank's Multilex DDF was the obvious choice, supporting prescribing, dispensing and administration decisions, helping our health professionals to provide the best patient care."

Multilex DDF is the UK's most comprehensive and widely used drug knowledge base. Multilex DDF holds clinical and commercial information on more than 75,000 pharmaceutical products and packs and provides patient specific clinical decision support. The integration of Multilex DDF in the Meditech Electronic Patient Record system provides the capability for Rotherham NHS Foundation Trust to develop a seamless clinical workflow, linking prescribing with other clinical functionality like orders and alerts to deliver easily managed, integrated care pathways.

Charles Blackburn, chief executive of FileTek UK, said "The implementation of MEDITECH v6.0 is the cornerstone in enabling the Trust to realise its clearly defined, ambitious IM & T strategy and vision of a 'paperless patient journey'. We are delighted to be partnering with First DataBank and incorporating its comprehensive UK drug knowledge base Multilex DDF within the MEDITECH v6.0 installation at Rotherham."

Related news articles:

About First DataBank
First DataBank is the UK's leading provider of drug knowledge bases and active clinical decision support. With over 30 years' experience of maintaining, developing and integrating drug knowledge bases across the entire healthcare spectrum, First DataBank has unrivalled expertise and knowledge in this specialist field. NHS Connecting for Health has chosen First DataBank to provide drug-related clinical decision support.

Patient safety is the driving force behind our business. Through the effective integration of our products into clinical systems, we enable safer prescribing, dispensing and administration.

Our Multilex Drug Data File - the UK's most comprehensive and widely used drug knowledge base - is in daily use by thousands of healthcare professionals in the UK.

For further information visit www.firstdatabank.co.uk.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...